{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:36:20Z","timestamp":1790422580290,"version":"4.1.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/01.aids.0000327512.76126.6e","type":"journal-article","created":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T07:11:00Z","timestamp":1223536260000},"page":"S19-S26","source":"Crossref","is-referenced-by-count":66,"title":["Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors"],"prefix":"10.1097","volume":"22","author":[{"given":"Franck","family":"Boccara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210130","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archinte.160.5.602","article-title":"Cardiac manifestations of acquired immunodeficiency syndrome","volume":"160","author":"Rerkpattanapipat","year":"2000","journal-title":"Arch Intern Med"},{"key":"R2-4-20210130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/bmj.309.6969.1605","article-title":"Heart muscle disease related to HIV infection: prognostic implications","volume":"309","author":"Currie","year":"1994","journal-title":"BMJ"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/heart.89.7.793","article-title":"HIV and cardiovascular medicine","volume":"89","author":"Prendergast","year":"2003","journal-title":"Heart"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0891-5520(01)00008-3","article-title":"Infective endocarditis in intravenous drug abusers and HIV-1 infected patients","volume":"16","author":"Miro","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"R5-4-20210130","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ahj.2005.07.030","article-title":"Cardiovascular disease in HIV infection","volume":"151","author":"Sudano","year":"2006","journal-title":"Am Heart J"},{"key":"R6-4-20210130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s15010-007-5125-0","article-title":"Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients","volume":"35","author":"De Rosa","year":"2007","journal-title":"Infection"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1161\/01.CIR.92.11.3229","article-title":"Pericardial effusion in AIDS: incidence and survival","volume":"92","author":"Heidenreich","year":"1995","journal-title":"Circulation"},{"key":"R8-4-20210130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1148\/rg.261055058","article-title":"Cardiovascular complications of human immunodeficiency virus infection","volume":"26","author":"Restrepo","year":"2006","journal-title":"Radiographics"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.100.5.1268","article-title":"Primary pulmonary hypertension in HIV infection","volume":"100","author":"Speich","year":"1991","journal-title":"Chest"},{"key":"R10-4-20210130","first-page":"1037","article-title":"HIV-related pulmonary hypertension","volume":"73","author":"Limsukon","year":"2006","journal-title":"Mt Sinai J Med"},{"key":"R11-4-20210130","first-page":"329","article-title":"Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study","volume":"5","author":"Rickerts","year":"2000","journal-title":"Eur J Med Res"},{"key":"R12-4-20210130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/375844","article-title":"Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population","volume":"37","author":"Sav\u00e8s","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/hrt.2005.068445","article-title":"Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis","volume":"92","author":"Boccara","year":"2006","journal-title":"Heart"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157016208783571900","article-title":"Coronary artery bypass graft in HIV-infected patients. A multicenter case control study","volume":"6","author":"Boccara","year":"2008","journal-title":"Curr HIV Res"},{"key":"R15-4-20210130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00134-003-1740-0","article-title":"Coronary artery disease in HIV infected patients","volume":"29","author":"Escaut","year":"2003","journal-title":"Intensive Care Med"},{"key":"R16-4-20210130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/324745","article-title":"Ischemic cardiovascular disease in persons with human immunodeficiency virus infection","volume":"34","author":"David","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R17-4-20210130","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-M\u00f8ller","year":"2007","journal-title":"N Engl J Med"},{"key":"R18-4-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-4-20210130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1568005054880163","article-title":"Insulin resistance in the HIV-infected population: the potential role of mitochondrial dysfunction","volume":"5","author":"Shikuma","year":"2005","journal-title":"Curr Drug Targets Infect Disord"},{"key":"R20-4-20210130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"R21-4-20210130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","article-title":"Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?","volume":"30","author":"Klein","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-4-20210130","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1097\/01.aids.0000247115.81832.a1","article-title":"Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use","volume":"20","author":"Kwong","year":"2006","journal-title":"AIDS"},{"key":"R23-4-20210130","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"R24-4-20210130","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"R25-4-20210130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/088922203766774487","article-title":"Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors","volume":"19","author":"Coplan","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R26-4-20210130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/09540120701203329","article-title":"Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort","volume":"19","author":"Vaughn","year":"2007","journal-title":"AIDS Care"},{"key":"R27-4-20210130","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"R28-4-20210130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","article-title":"Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents","volume":"90","author":"Tunstall-Pedoe","year":"1994","journal-title":"Circulation"},{"key":"R29-4-20210130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"R30-4-20210130","first-page":"204","article-title":"Atherosclerosis in HIV patients: a new face for an old disease?","volume":"8","author":"Maggi","year":"2006","journal-title":"AIDS Rev"},{"key":"R31-4-20210130","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1097\/QAD.0b013e3280108704","article-title":"Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses","volume":"20","author":"Hsue","year":"2006","journal-title":"AIDS"},{"key":"R32-4-20210130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1468-1293.2006.00362.x","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study","volume":"7","author":"Law","year":"2006","journal-title":"HIV Med"},{"key":"R33-4-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.163.4.457","article-title":"Acute myocardial infarction in human immunodeficiency virus-infected patients","volume":"163","author":"Matetzky","year":"2003","journal-title":"Arch Intern Med"},{"key":"R34-4-20210130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"R35-4-20210130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ahj.2003.07.007","article-title":"Acute myocardial infarction in patients infected with human immunodeficiency virus","volume":"147","author":"Varriale","year":"2004","journal-title":"Am Heart J"},{"key":"R36-4-20210130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9149(03)00631-3","article-title":"Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"92","author":"Ambrose","year":"2003","journal-title":"Am J Cardiol"},{"key":"R38-4-20210130","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1097\/00002030-200011100-00001","article-title":"Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors","volume":"14","author":"Maggi","year":"2000","journal-title":"AIDS"},{"key":"R39-4-20210130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00002030-200102160-00005","article-title":"Premature atherosclerosis in HIV-infected individuals \u2013 focus on protease inhibitor therapy","volume":"15","author":"Depairon","year":"2001","journal-title":"AIDS"},{"key":"R40-4-20210130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/078538902317338652","article-title":"Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement","volume":"34","author":"Mercie","year":"2002","journal-title":"Ann Med"},{"key":"R41-4-20210130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/01.STR.0000204037.26797.7f","article-title":"Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy","volume":"37","author":"Jerico","year":"2006","journal-title":"Stroke"},{"key":"R42-4-20210130","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516616","article-title":"Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV","volume":"44","author":"Mangili","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R43-4-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0021-9150(02)00016-3","article-title":"Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: a call for cardiovascular prevention","volume":"163","author":"Acevedo","year":"2002","journal-title":"Atherosclerosis"},{"key":"R44-4-20210130","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archinte.165.6.690","article-title":"Human immunodeficiency virus 1 infection, cocaine, and coronary calcification","volume":"165","author":"Lai","year":"2005","journal-title":"Arch Intern Med"},{"key":"R45-4-20210130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.mol.0000174400.68938.f6","article-title":"Surrogate markers for atherosclerotic disease","volume":"16","author":"Sankatsing","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"R46-4-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1468-1293.2002.00117.x","article-title":"Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998\u20131999","volume":"3","author":"Bonnet","year":"2002","journal-title":"HIV Med"},{"key":"R47-4-20210130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0399-077X(04)00146-5","article-title":"Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART)","volume":"34","author":"Lewden","year":"2004","journal-title":"Med Mal Infect"},{"key":"R48-4-20210130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-145-6-200609190-00003","article-title":"Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City","volume":"145","author":"Sackoff","year":"2006","journal-title":"Ann Intern Med"},{"key":"R49-4-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R50-4-20210130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"Fontas","year":"2004","journal-title":"J Infect Dis"},{"key":"R51-4-20210130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/01.qai.0000138420.38995.86","article-title":"Tolerability and safety of HIV protease inhibitors in adults","volume":"37","author":"Sax","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R52-4-20210130","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1161\/CIRCULATIONAHA.105.546465","article-title":"What a cardiologist needs to know about patients with human immunodeficiency virus infection","volume":"112","author":"Hsue","year":"2005","journal-title":"Circulation"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200809003-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:23:59Z","timestamp":1618280639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200809003-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":51,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000327512.76126.6e","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}